A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
Clinical trial NCT01637402 · COMPLETED
Trial details
- NCT number
- NCT01637402
- Sponsor
- Terence Friedlander, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-13
- Primary completion
- 2017-02-27
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.